Vital KSK HoldingsTSE:3151 +0.53%71 Shareholder Yield % is 5.44% as of Mar. 2026, which is 46% above its 10-year median of 3.73. GuruFocus rates TSE:3151 with a GF Score™ of 71/100 and a GF Value™ of 円1,323.86 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 113 Medical Distribution companies, Vital KSK Holdings ranks better than 64.6% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Vital KSK Holdings's Shareholder Yield % was 5.44%.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Vital KSK Holdings Shareholder Yield % Related Terms
Vital KSK Holdings Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Vital KSK Holdings's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3151 vs MCK, CAH, COR: Shareholder Yield % Comparison
For the Medical Distribution subindustry, Vital KSK Holdings's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital KSK Holdings Shareholder Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Vital KSK Holdings's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Vital KSK Holdings (TSE:3151) has a Shareholder Yield % of 5.44% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Vital KSK Holdings and its competitors. This is 46% above median its historical median of 3.73. According to the industry distribution chart, Vital KSK Holdings ranks #40 out of 113 companies in the Medical Distribution industry, placing it in the top 35.4%.
Is Vital KSK Holdings' Shareholder Yield % too high?
Vital KSK Holdings' current Shareholder Yield % of 5.44% is 46% above median its 10-year median of 3.73. The Medical Distribution industry median Shareholder Yield % is 2.33. Vital KSK Holdings' value of 5.44% is 133.5% above this industry median. Based on the distribution chart, Vital KSK Holdings ranks #40 out of 113 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Vital KSK Holdings has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' Shareholder Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Vital KSK Holdings ranks #40 out of 113 companies for Shareholder Yield %. This puts Vital KSK Holdings in the upper half of its industry. The industry median Shareholder Yield % is 2.33. Vital KSK Holdings' value of 5.44% is 133.5% above this benchmark. While the company's 10-year median is 3.73 vs. the industry median of 2.33, Vital KSK Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Distribution company?
The median Shareholder Yield % among Medical Distribution companies is 2.33, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital KSK Holdings's current Shareholder Yield % of 5.44% is 133.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Vital KSK Holdings and its competitors. For the Medical Distribution industry, the median Shareholder Yield % is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital KSK Holdings's current Shareholder Yield % is 5.44%, which is 46% above median its own 10-year median of 3.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,323.86, compared to a current price of 円1,526.00 — trading 15.3% above its estimated fair value. The current Shareholder Yield % is 5.44%, which is 46% above median its 10-year median of 3.73 and 133.5% above the Medical Distribution industry median of 2.33. Vital KSK Holdings' overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current Shareholder Yield % is 5.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?
Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued.
The current stock price of 円1,526.00 is trading 15.3% above its estimated GF Value™ of 円1,323.86.
GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.
Key valuation signals for TSE:3151:
Shareholder Yield %: 5.44% (46% above median its 10-year median of 3.73)
GF Value™: 円1,323.86 vs. price of 円1,526.00 (15.3% above fair value)
Industry Position: 133.5% above the Medical Distribution median (#40 of 113)
No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
71GF Score
Get the complete analysis for TSE:3151
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3151 has been successfully added to your 
